Trials / Completed
CompletedNCT00928486
A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma
A Safety Confirmation Study On Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of lenalidomide with dexamethasone in Japanese patients with previously treated multiple myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lenalidomide | Lenalidomide 25mg PO for (days 1 - 21) of a 28-day cycle |
| DRUG | Dexamethasone | Dexamethasone 40 mg by mouth (PO) daily (QD) on days 1-4, 9-12 and 17-20 of each 28 day cycle |
Timeline
- Start date
- 2009-04-28
- Primary completion
- 2010-09-10
- Completion
- 2010-09-10
- First posted
- 2009-06-26
- Last updated
- 2019-11-20
- Results posted
- 2016-06-14
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00928486. Inclusion in this directory is not an endorsement.